Dr. Karen Reckamp

Dr. Karen Reckamp, a thoracic oncologist at Cedars-Sinai, and Dr. Scott Atay, a thoracic surgeon at USC, delve into the complexities of lung cancer treatment. They discuss the latest in lung cancer staging and cutting-edge systemic therapies. Key insights include the evolving role of molecular diagnostics, the importance of tailored treatment plans, and the integration of new therapies in surgical decision-making. They also explore the implications of pollution and genetic factors on non-smoker EGFR risks, highlighting a future focused on personalized cancer care.

Join Dr. Karen Reckamp, a medical oncologist focused on neoadjuvant strategies, Dr. Scott Oh, a radiation oncologist discussing local therapies, and Dr. Scott Atay, an interventional pulmonologist specializing in staging, as they tackle a complex NSCLC case. They debate the best approaches for treating isolated brain metastasis, the implications of nodal disease, and the optimal sequencing of chemoimmunotherapy and radiation. Their multidisciplinary insights shed light on the balance between surgical risks and systemic benefits in challenging cancer cases.

Dr. Karen Reckamp, a thoracic oncologist, joins Dr. Alan Lee, a radiation oncologist, Dr. Scott Atay, a thoracic surgeon, and Dr. Scott Oh, an interventional pulmonologist, for a rich discussion on lung cancer management. They explore the dynamics of tumor boards, emphasizing collaborative decision-making and the benefits of hybrid meetings post-COVID. The panel dives into the significance of tissue diagnosis, mediastinal staging, and the evolving role of ablation therapy, highlighting challenges and strategies in treating early-stage and metastatic lung cancer.